Noninvasive diagnosis of coronary artery disease in women

Area of Science:

• Cardiology
• Women's Health
• Diagnostic Imaging

Background:

• Cardiovascular disease (CVD) is the primary cause of death and morbidity in US women.
• Challenges in CVD diagnosis include lack of early symptoms, risk of sudden fatal events, and limitations of current noninvasive tests.
• Accurate risk stratification is crucial for effective patient management.

Purpose of the Study:

• To critically evaluate the diagnostic accuracy of noninvasive tests for coronary artery disease (CAD) specifically in women.
• To provide healthcare practitioners with an evidence-based overview to improve risk stratification strategies for female patients.
• To highlight the importance of understanding sex-specific differences in CAD presentation and diagnosis.

Main Methods:

• Systematic review of existing literature on noninvasive diagnostic tests for CAD in women.
• Analysis of studies focusing on the performance of various noninvasive modalities (e.g., stress tests, imaging).
• Comparison of diagnostic accuracy metrics across different tests and patient populations.

Main Results:

• Noninvasive tests show variable accuracy for CAD diagnosis in women, often influenced by factors like body habitus and hormonal status.
• Certain noninvasive strategies may be less sensitive or specific in women compared to men, necessitating careful interpretation.
• Emerging noninvasive technologies show promise but require further validation in diverse female cohorts.

Conclusions:

• Current noninvasive diagnostic tests for CAD in women have limitations that impact accurate risk stratification.
• Further research and development of sex-specific diagnostic tools are essential for improving cardiovascular care in women.
• Optimizing noninvasive testing protocols and interpretation is key to reducing mortality and morbidity from CAD in this population.